May 29th 2025
In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
BeiGene Selects GE Healthcare’s Biologics Factory to Boost its Manufacturing Capacity
September 20th 2018BeiGene is set to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies.
SGS Implements Advanced Techniques for PBMCs
September 6th 2018The pharmaceutical, clinical, and bioanalytical contract solutions provider has implemented advanced techniques for the collection and use of peripheral blood mononuclear cells (PBMCs) for early-phase clinical trials at its Clinical Pharmacology Unit in Antwerp, Belgium.